The Journal of Immunology, Vol 152, Issue 9 4526-4536, Copyright © 1994 by American Association of Immunologists

ARTICLES

A disease-related epitope of Torpedo acetylcholine receptor. Residues involved in I-Ab binding, self-nonself discrimination, and TCR antagonism

KA Wall, JY Hu, P Currier, S Southwood, A Sette and AJ Infante
Department of Medicinal and Biological Chemistry, College of Pharmacy, University of Toledo, OH 43606.

Residues 146-162 of the Torpedo californica acetylcholine receptor alpha-subunit contain the immunodominant T cell epitope for experimental autoimmune myasthenia gravis-susceptible C57BL/6 mice. To develop potential therapeutic peptides, a detailed analysis of the epitope was undertaken. Truncated and substituted synthetic peptides were tested as stimulators of T cell clones and immune lymph node cells. Critical residues spanned positions 151-159. Y151 and V156 were critical for MHC binding. The results indicated a general motif for binding to I-Ab to be an aromatic or hydrophobic residue (preferentially Y or F) at position i followed by an uncharged residue at position (i + 5). Lysine was not tolerated at position (i + 8). Residues D152, K155, S157, and I158 were important T cell contact residues. A peptide corresponding to the murine 146-162 sequence, which differs from the Torpedo sequence at 5 residues, bound to I-Ab but was nonimmunogenic, consistent with the assigned TCR and I-Ab contact residues. These results suggest that tolerance is responsible for the lack of T cell cross-reactivity with the murine acetylcholine receptor. Substituted peptides were tested for the inhibition of T cell clone responses and for TCR antagonism. Although peptides substituted at residues 157 and 158 inhibited most clones, no single peptide could completely inhibit all clones or primed lymph node cells. These findings indicate that antagonist peptides may be useful in inhibiting T cell responses to complex Ag displaying a single immunodominant epitope. Multiple antagonists used in combination may be required for maximum inhibition of the response.

This article has been cited by other articles:

				M. Moutaftsi, H.-H. Bui, B. Peters, J. Sidney, S. Salek-Ardakani, C. Oseroff, V. Pasquetto, S. Crotty, M. Croft, E. J. Lefkowitz, et al. Vaccinia Virus-Specific CD4+ T Cell Responses Target a Set of Antigens Largely Distinct from Those Targeted by CD8+ T Cell Responses J. Immunol., June 1, 2007; 178(11): 6814 - 6820. [Abstract] [Full Text] [PDF]

				N. E. Standifer, S. Stacy, E. Kraig, and A. J. Infante Discrete T Cell Populations with Specificity for a Neo-Self-Antigen Bear Distinct Imprints of Tolerance J. Immunol., March 15, 2007; 178(6): 3544 - 3550. [Abstract] [Full Text] [PDF]

				D. Anghelina, L. Pewe, and S. Perlman Pathogenic Role for Virus-Specific CD4 T Cells in Mice with Coronavirus-Induced Acute Encephalitis Am. J. Pathol., July 1, 2006; 169(1): 209 - 222. [Abstract] [Full Text] [PDF]

				C. J. Guyver, D. A. Copland, C. J. Calder, A. Sette, J. Sidney, A. D. Dick, and L. B. Nicholson Mapping Immune Responses to mRBP-3 1-16 Peptide with Altered Peptide Ligands Invest. Ophthalmol. Vis. Sci., May 1, 2006; 47(5): 2027 - 2035. [Abstract] [Full Text] [PDF]

				H. Sahara and N. Shastri Second Class Minors: Molecular Identification of the Autosomal H46 Histocompatibility Locus as a Peptide Presented by Major Histocompatibility Complex Class II Molecules J. Exp. Med., February 3, 2003; 197(3): 375 - 385. [Abstract] [Full Text] [PDF]

				S. Stacy, B. E. Gelb, B. A. Koop, J. J. Windle, K. A. Wall, K. A. Krolick, A. J. Infante, and E. Kraig Split Tolerance in a Novel Transgenic Model of Autoimmune Myasthenia Gravis J. Immunol., December 1, 2002; 169(11): 6570 - 6579. [Abstract] [Full Text] [PDF]

				B. Livingston, C. Crimi, M. Newman, Y. Higashimoto, E. Appella, J. Sidney, and A. Sette A Rational Strategy to Design Multiepitope Immunogens Based on Multiple Th Lymphocyte Epitopes J. Immunol., June 1, 2002; 168(11): 5499 - 5506. [Abstract] [Full Text] [PDF]

				M. D. Meeks, T. K. Wade, R. K. Taylor, and W. F. Wade Immune Response Genes Modulate Serologic Responses to Vibrio cholerae TcpA Pilin Peptides Infect. Immun., December 1, 2001; 69(12): 7687 - 7694. [Abstract] [Full Text] [PDF]

				L. Santambrogio, A. K. Sato, F. R. Fischer, M. E. Dorf, and L. J. Stern Abundant empty class II MHC molecules on the surface of immature dendritic cells PNAS, December 21, 1999; 96(26): 15050 - 15055. [Abstract] [Full Text] [PDF]

				M. A. Purbhoo, A. K. Sewell, P. Klenerman, P. J. R. Goulder, K. L. Hilyard, J. I. Bell, B. K. Jakobsen, and R. E. Phillips Copresentation of natural HIV-1 agonist and antagonist ligands fails to induce the T cell receptor signaling cascade PNAS, April 14, 1998; 95(8): 4527 - 4532. [Abstract] [Full Text] [PDF]